SCHEMBL20249693

SCHEMBL20249693

Cc1c2c(-c3ccccc3)nc3cc(-c4ccc(-c5nc(-c6ccccc6)cc(-c6ccccc6)n5)cc4)ccc3c2c(C)c2c(-c3ccccc3)nc3ccccc3c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 3/20 0.44
MEN1 O00255 7/20 0.42
KMT2A Q03164 7/20 0.42
ALDH1A1 P00352 5/20 0.42
MAPT P10636 5/20 0.42
HPGD P15428 4/20 0.42
NTSR1 P30989 1/20 0.42
DHFR P00374 1/20 0.42
KDM4E B2RXH2 2/20 0.41
POLB P06746 1/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
PDE10A Q9Y233 2/20 0.40
TSHR P16473 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
CYP1A1 P04798 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP1B1 Q16678 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24222295 1.00 DHODH (0.44) DHODHMEN1KMT2AALDH1A1MAPT
SCHEMBL24222394 0.96 MEN1 (0.43) DHODHMEN1KMT2AALDH1A1MAPT
SCHEMBL20249628 0.95 MEN1 (0.43) DHODHMEN1KMT2AALDH1A1MAPT
SCHEMBL20245084 0.94 DHODH (0.43) DHODHMEN1KMT2AALDH1A1MAPT
SCHEMBL20249671 0.94 MEN1 (0.40) DHODHMEN1KMT2AALDH1A1MAPT
SCHEMBL20249691 0.94 DHODH (0.47) DHODHMEN1KMT2ADHFRATM
SCHEMBL20249645 0.91 DHODH (0.51) DHODHALDH1A1DHFRKDM4EPKM
SCHEMBL20249732 0.90 DHODH (0.47) DHODHMEN1KMT2AALDH1A1MAPT
SCHEMBL20249646 0.90 MEN1 (0.48) DHODHMEN1KMT2AALDH1A1KDM4E
SCHEMBL20249676 0.89 CYP19A1 (0.43) DHODHMEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3333168-B1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO LTD (KR) 2022-01-26 EP disclosed
US-10693083-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-23 US disclosed
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 DHODH 1907/4885MEN1 394/4885KMT2A 1848/4885
US-10693083-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 DHODH 1907/4885MEN1 394/4885KMT2A 1848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.